RecallDepth
Class II Ongoing

Diltiazem Hydrochloride Extended-Release Capsules, USP 120mg, Twice-a-Day Dosage, Rx Only, 100 Capsules per bottle, Mfd for: Northstar Rx LLC, Memphis, TN, Mfd by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya Pradesh India, NDC 16714-555-01.

This recall is currently active, issued December 11, 2024. It was issued by Glenmark Pharmaceuticals Inc., Usa.

Company
Glenmark Pharmaceuticals Inc., Usa
Recall Initiated
November 1, 2024
Posted
December 11, 2024
Recall Number
D-0098-2025
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
7296 bottles
Firm Location
Mahwah, NJ, United States
Official Source
View on FDA website ↗

Reason for Recall

cGMP Deviations: Presence of N-nitroso-Desmethyl-Diltiazem impurity above FDA recommended interim limit.

Distribution

Nationwide in the USA

Lot / Code Info

Lot #:17222547, Exp. Date, 11/30/2024; 17230598, Exp. Date 02/28/2025

More recalls by Glenmark Pharmaceuticals Inc., Usa

View all recalls by this company →

Other recent Class II Drug recalls